Most enterprise security programs have an uncomfortable truth sitting on their risk registers. They test a small fraction of their attack surface, and they know it. Recent research from Omdia puts the ...

For children with suspected rare diseases, access to timely genomic testing remains uneven and, too often, out of reach. Too many families are left stranded in the gap between what insurance covers on ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...